AbbVie (ABBV) Goes Down as Barclays Downgrades

AbbVie Inc (NYSE: ABBV) shares declined 0.6% to $57.79. Barclays downgraded AbbVie from overweight to equal-weight and lowered the price target from $73.00 to $72.00. Share volume was one million, compared to an all-day average of 2.7 million